# Explainable AI for Cancer Drug Response Prediction: Beyond Univariate Feature Attributions

Source: [Explainable AI for Cancer Drug Response Prediction: Beyond Univariate Feature Attributions](<https://www.sota2.com/research/paper/6a45f094dc71372d7795a32d>)

Collection index: [llms.txt](<https://www.sota2.com/research/llms.txt>)

Data updated: 2026-07-03T05:00:11.862Z

Authors: Martino Ciaperoni, Margherita Lalli, Simone Piaggesi, Martina Varisco, Francesco Carli, Riccardo Guidotti, Dino Pedreschi, Francesco Raimondi, Fosca Giannotti

Published: 2026-07-01T13:34:04.000Z

## Abstract

Predicting cancer drug response from transcriptomic profiles is a cornerstone of precision oncology, yet the scientific value of machine learning models hinges not solely on predictive accuracy, but also on their capacity to generate reliable biological insights. Current explainability approaches in this setting are computationally costly, lack robustness, and reduce complex drug response to univariate gene importance scores, overlooking the coordinated gene activity that drives sensitivity and resistance. In this work, we present ILLUME+, a scalable post-hoc explainability framework that moves beyond single-gene assessments to capture multiple, complementary forms of explanation. Integrated into our end-to-end pipeline, ILLUME+ produces more stable gene importance scores than existing baselines, recovers established drug-gene associations and mechanisms of action, and enables AI-assisted hypothesis generation to uncover novel interaction-driven molecular signals in cancer biology.

## Recorded benchmark results

A research result applies to its stated dataset, split, metric and evaluation configuration. Compare like-for-like settings, preserve the metric's unit and direction, and distinguish paper-reported results from independent reproduction. The best result recorded here is not a claim of exhaustive, current global coverage.

- [Cancer drug response prediction on PRISM (aggregated train val test)](<https://www.sota2.com/research/sota/cancer-drug-response-prediction-on-prism-aggregated-train-val-test.md>): Cancer drug response prediction; PRISM (aggregated train val test); Mean Robustness: 0.3058.

## Original sources and implementation

[Original paper](<https://arxiv.org/abs/2607.00931>)

[PDF](<https://arxiv.org/pdf/2607.00931.pdf>)
